Disease modeling in TNPO2 brain organoids.

Disease modeling through drosophila melanogaster.

Partnership with company developing therapeutics based on antisense technology.

Developing an antibody to measure mutant protein levels.

Transcriptomic disease modeling and small molecule drug screen.

Disease modeling and drug screening in c. elegans (worm) and s. cerevisiae (yeast).

Mouse model generation.